Cue Biopharma Inc buy Stifel Nicolaus
Start price
22.03.23
/
50%
€3.00
Target price
22.03.24
€7.41
Performance (%)
-42.17%
End price
23.03.24
€1.74
Summary
This prediction ended on 23.03.24 with a price of €1.74. The BUY prediction by Stifel_Nicolaus for Cue Biopharma Inc performed very badly with a performance of -42.17%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cue Biopharma Inc | 109.322% | 109.322% | -25.378% | -84.085% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten